tiprankstipranks
GlaxoSmithKline (GSK)
NYSE:GSK
US Market

GlaxoSmithKline (GSK) Technical Analysis

Compare
4,903 Followers

Technical Sentiment

Overall Consensus
Buy
13Bullish
6Neutral
3Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
GlaxoSmithKline’s (GSK) Moving Averages Convergence Divergence (MACD) indicator is 0.65, suggesting GlaxoSmithKline is a Sell.
GlaxoSmithKline’s (GSK) 20-Day exponential moving average is 35.81, while GlaxoSmithKline’s (GSK) share price is $36.96, making it a Buy.
GlaxoSmithKline’s (GSK) 50-Day exponential moving average is 35.29, while GlaxoSmithKline’s (GSK) share price is $36.96, making it a Buy.

GlaxoSmithKline (GSK) Pivot Points

Feb 22, 2025, 12:15 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
36.08
36.22
36.38
36.51
36.67
36.81
36.97
Fibonacci
36.22
36.33
36.40
36.51
36.62
36.69
36.81
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

GlaxoSmithKline (GSK) Moving Averages

Feb 22, 2025, 12:15 AM
Period
Simple
Exponential
MA5
36.57Buy
36.60Buy
MA10
36.39Buy
36.34Buy
MA20
35.80Buy
35.81Buy
MA50
34.61Buy
35.29Buy
MA100
35.61Buy
35.97Buy
MA200
38.23Sell
37.78Sell
GlaxoSmithKline’s (GSK) 10-Day exponential moving average is 36.34, while GlaxoSmithKline’s (GSK) share price is $36.96, making it a Buy.
GlaxoSmithKline’s (GSK) 100-Day exponential moving average is 35.97, while GlaxoSmithKline’s (GSK) share price is $36.96, making it a Buy.
GlaxoSmithKline’s (GSK) stock price is $36.96 and GlaxoSmithKline’s (GSK) 50-day simple moving average is 34.61, creating a Buy signal.
GlaxoSmithKline’s (GSK) stock price is $36.96 and GlaxoSmithKline’s (GSK) 100-day simple moving average is 35.61, creating a Buy signal.
GlaxoSmithKline’s (GSK) stock price is $36.96 and GlaxoSmithKline’s (GSK) 200-day simple moving average is 38.23, creating a Sell signal.

GlaxoSmithKline (GSK) Technical Indicators

Feb 22, 2025, 12:15 AM
Name
Value
Implied Action
RSI (14)
61.74
Neutral
STOCH (9,6)
59.52
Neutral
STOCHRSI (14)
67.28
Neutral
MACD (12,26)
0.65
Sell
ADX (14)
21.34
Neutral
Williams %R
-25.76
Buy
CCI (14)
91.99
Neutral
ATR (14)
0.71
-
Ultimate Oscillator
58.65
Neutral
ROC
4.52
Buy
GlaxoSmithKline’s (GSK) Relative Strength Index (RSI) is 61.74, creating a Neutral signal.
GlaxoSmithKline’s (GSK) Trend Strength Indicator (ADX) is 21.34, creating a Neutral signal.
GlaxoSmithKline’s (GSK) Commodity Channel Index (CCI) is 91.99, creating a Neutral signal.
GlaxoSmithKline’s (GSK) Price Rate of Change (ROC) is 4.52, creating a Buy signal.

FAQ

Is GSK a Buy, Hold, or Sell?
Based on GSK’s technical indicators, GSK is a Buy.
    What is GSK’s RSI (14)?
    GSK’s RSI (14) is 61.74, which suggests GSK is a Neutral.
      What is GSK’s MACD?
      GSK’s MACD is 0.65, which suggests GSK is a Sell.
        What is GSK’s 5-day moving average?
        GSK’s 5-day moving average is 36.57, which suggests GSK is a Buy.
          What is GSK’s 20-day moving average?
          GSK 20-day moving average is 35.80, which suggests GSK is a Buy.
            What is GSK’s 50-day moving average?
            GSK’s 50-day moving average is 34.61, which suggests GSK is a Buy.
              What is GSK’s 200-day moving average?
              GSK’s 200-day moving average is 38.23, which suggests GSK is a Sell.
                What is GSK’s Williams % R (14)?
                GSK’s Williams % R (14) is -25.76, which suggests GSK is a Buy.
                  What is GSK’s CCI (14)?
                  GSK’s CCI (14) is 91.99, which suggests GSK is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis